The National Institute of Neurological Disorders and Stroke (NINDS) Parkinson’s Disease Biomarkers Program (PDBP) was developed to accelerate the discovery of promising new diagnostic and progression biomarkers for Parkinson’s Disease.
The Parkinson’s Disease Biomarkers Program (PDBP) is made up of researchers, patients, family members, and healthcare professionals who are dedicated to accelerating the pace of biomarkers research.
The PDBP supports basic, translational and clinical research through hypothesis testing, target and pathway discovery, biomarker development, and disease modeling through broadly sharing clinical data, associated cell lines, and biospecimens developed under this program.